Heme oxygenase-1 (HO-1) expression in prostate cancer cells modulates the oxidative response in bone cells

• Published in: PloS one Vol. 8; no. 11; p. e80315
• Main Authors: Ferrando, Mercedes, Wan, Xinhai, Meiss, Roberto, Yang, Jun, De Siervi, Adriana, Navone, Nora, Vazquez, Elba
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 04.11.2013; Public Library of Science (PLoS)
• Subjects: Angiogenesis; Animals; B cells; Biocompatibility; Biomedical materials; Blotting, Western; Bone cancer; Bone growth; Bone remodeling; Bone tumors; Cancer; Cancer cells; Cancer metastasis; Cell culture; Cell Cycle - drug effects; Cell growth; Cell Line; Cell Line, Tumor; Cell migration; Cell proliferation; Cell Proliferation - drug effects; Cells, Cultured; Change detection; Complications; Enzymes; Explants; Femur; Flow Cytometry; Forkhead protein; Gene expression; Heme; Heme oxygenase (decyclizing); Heme Oxygenase-1 - genetics; Heme Oxygenase-1 - metabolism; Hemin; Hemin - pharmacology; Humans; Immunoglobulins; Immunohistochemistry; Impact analysis; Inflammation; Laboratories; Male; Males; Metastases; Metastasis; Mice; Mice, SCID; Oncology; Organ Culture Techniques; Osteoblastogenesis; Osteoblasts; Osteoblasts - drug effects; Osteoblasts - metabolism; Osteogenesis; Oxidative stress; Oxygenase; Pharmacology; Prostate cancer; Prostatic Neoplasms - genetics; Prostatic Neoplasms - metabolism; Rodents; Signaling; Stem cells; Tumor cells; Tumors; United States > US; Argentina; Texas
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0080315

Prostate cancer (PCa) is a leading cause of death among males. It is currently estimated that inflammatory responses are linked to 15-20% of all deaths from cancer worldwide. PCa is dominated by complications arising from metastasis to the bone where the tumor cells interact with the bone microenvironment impairing the balance between bone formation and degradation. However, the molecular nature of this interaction is not completely understood. Heme oxygenase-1 (HO-1) counteracts oxidative damage and inflammation. Previous studies from our laboratory showed that HO-1 is implicated in PCa, demonstrating that endogenous HO-1 inhibits bone derived-prostate cancer cells proliferation, invasion and migration and decreases tumor growth and angiogenesis in vivo. The aim of this work was to analyze the impact of HO-1 modulated PCa cells on osteoblasts proliferation in vitro and on bone remodeling in vivo. Using a co-culture system of PC3 cells with primary mice osteoblasts (PMOs), we demonstrated that HO-1 pharmacological induction (hemin treatment) abrogated the diminution of PMOs proliferation induced by PCa cells and decreased the expression of osteoclast-modulating factors in osteoblasts. No changes were detected in the expression of genes involved in osteoblasts differentiation. However, co-culture of hemin pre-treated PC3 cells (PC3 Hem) with PMOs provoked an oxidative status and activated FoxO signaling in osteoblasts. The percentage of active osteoblasts positive for HO-1 increased in calvarias explants co-cultured with PC3 Hem cells. Nuclear HO-1 expression was detected in tumors generated by in vivo bone injection of HO-1 stable transfected PC3 (PC3HO-1) cells in the femur of SCID mice. These results suggest that HO-1 has the potential to modify the bone microenvironment impacting on PCa bone metastasis.